CIK 0000822370 · Non-accelerated filer<br>Smaller reporting company
Emmaus Life Sciences, Inc.
Sign in to watch- Ticker
- EMMA
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 870419387
- Phone
- 310-214-0065
- Business address
- 21250 HAWTHORNE BOULEVARD, SUITE 800, TORRANCE, CA, 90503
- Former names
- MYnd Analytics, Inc., CNS RESPONSE, INC., STRATIVATION, INC., SalesTactix, Inc., AGE RESEARCH INC
- 8-K Event Other events
- DEFA14A Proxy Proxy Materials
- PREC14A Other PREC14A
- DFAN14A Other Proxy Soliciting Materials
- DFAN14A Other Proxy Soliciting Materials
- 8-K Event Other events
- DEFA14A Proxy Proxy Materials
- 4 Open-market buy Director bought 3,333,334 shares at $0.30 ($1,000,000)
- DFAN14A Other Proxy Soliciting Materials
- SC 13D/A Stake Beneficial Ownership Report
- 4 Conversion Director acquired 956,164 shares (conversion)
- 4 Open-market buy 10% owner bought 1,080,000 shares at $0.30 ($324,000)
- 4 Open-market buy 10% owner bought 1,080,000 shares at $0.30 ($324,000)
- 4 Open-market buy Director bought 1,080,000 shares at $0.30 ($324,000)
- SC 13D/A Stake Beneficial Ownership Report
- 8-K Event Material agreement · Unregistered share sale · Executive or director change
- DFAN14A Other Proxy Soliciting Materials
- DFAN14A Other Proxy Soliciting Materials
- 8-K Event Other events
- DEFA14A Proxy Proxy Materials
Page 51 of 63 · 1,250 filings